Ep. 87: Taking a Customized and Collaborative Approach to Therapeutic Development

Sounds of Science

Player FM - Internet Radio Done Right

66 subscribers

Biotech

Pharmacology

הוסף לפני seven שנים

תוכן מסופק על ידי Sounds of Science and Charles River. כל תוכן הפודקאסטים כולל פרקים, גרפיקה ותיאורי פודקאסטים מועלים ומסופקים ישירות על ידי Sounds of Science and Charles River או שותף פלטפורמת הפודקאסט שלהם. אם אתה מאמין שמישהו משתמש ביצירה שלך המוגנת בזכויות יוצרים ללא רשותך, אתה יכול לעקוב אחר התהליך המתואר כאן https://he.player.fm/legal.

All About Change

1
Professional football player Jonathan Jones: Mentorship and Making an Impact in Your Community 22:49

לפני 10 ימים22:49

הפעל מאוחר יותר

רשימות

לייק

אהבתי

22:49

Jonathan Jones is an NFL cornerback for the Washington Commanders who rose from the undrafted ranks to become two-time Super Bowl champion with the New England Patriots, a businessman, philanthropist, and licensed pilot. In 2019, Jonathan founded the Jonathan Jones Next Step Foundation in 2019, a platform dedicated to empowering youth through education, professional development, and mentorship. The foundation works to alleviate food insecurity, promote women in stem and sports, and to promote professional development in the communities where he lives. Jay and Jonathan talk about investing in the communities they live in, acknowledging the people who helped you become the person you are, and paying that same investment forward to the next generation. Episode Chapters 0:00 intro 1:24 Building local connections 4:25 Jonathan’s mentors and mentees 10:54 Jonathan’s pride in his mentees’ successes 13:04 how Jonathan chooses his causes 14:08 Jonathan’s support for girls and young women 17:19: Jonathan’s passion for flying 19:40 The Next Step Foundation 20:29 Goodbye For video episodes, watch on www.youtube.com/@therudermanfamilyfoundation Stay in touch: X: @JayRuderman | @RudermanFdn LinkedIn: Jay Ruderman | Ruderman Family Foundation Instagram: All About Change Podcast | Ruderman Family Foundation To learn more about the podcast, visit https://allaboutchangepodcast.com/ Looking for more insights into the world of activism? Be sure to check out Jay’s brand new book, Find Your Fight , in which Jay teaches the next generation of activists and advocates how to step up and bring about lasting change. You can find Find Your Fight wherever you buy your books, and you can learn more about it at www.jayruderman.com .…

לפני שנה 28:49

MP3•בית הפרקים

Join us as Executive Director Hugh Hempel discusses the origins of N=1, the collaborative effort it takes to advance customized therapies down the pipeline, and what the future holds for the field of individualized medicine.

Show Notes

n=1 Collaborative

Rare Disease | Charles River

Rare Disease Research for Drug Development

Repurposing Drugs for Rare Disease

S4 E07: Free For Life: The Story of N-Lorem Foundation

92 פרקים

#Tech #Drugdiscovery #Pharmaceutical #Research #Charles River #Biotech #Science #Natural Sciences #Pharmacology #Medicine #Sounds Of Science

Sounds of Science

Ep. 87: Taking a Customized and Collaborative Approach to Therapeutic Development

Sounds of Science

66 subscribers

published לפני שנה

שתפו

MP3•בית הפרקים

Show Notes

n=1 Collaborative

Rare Disease | Charles River

Rare Disease Research for Drug Development

Repurposing Drugs for Rare Disease

S4 E07: Free For Life: The Story of N-Lorem Foundation

92 פרקים

#Tech #Drugdiscovery #Pharmaceutical #Research #Charles River #Biotech #Science #Natural Sciences #Pharmacology #Medicine #Sounds Of Science

כל הפרקים

Sounds of Science

1
Evolving Animal Welfare: Science, Ethics, and Innovation 30:03

לפני 9 ימים30:03

30:03

Are we on the brink of a major shift in research? In this episode of Sounds of Science , Charles River experts challenge traditional approaches, exploring cutting-edge innovations that enhance animal welfare while driving scientific breakthroughs. From revolutionary non-animal testing methods to advanced behavioral management strategies, we uncover how ethical care leads to better data and faster drug discovery. Tune in to discover how science, compassion, and innovation are shaping the next era of drug development. Show Notes Animals in Research | 3Rs Alternative Methods Advancement Project CHARTER Program for Lab Animal Welfare Advancing Responsible Science…

Sounds of Science

1
Cancer Vaccines, Then and Now 34:34

לפני 23 ימים34:34

34:34

Did you know that the first attempt at a cancer vaccine was all the way back in the 1800s? I am joined by Charles River experts Louise Brackenbury, Dan Rocca, and Mike Templin to discuss the fascinating science behind therapeutic cancer vaccines. Clarification: Coley’s Toxin is not a vaccine in the traditional sense, but a compound developed by William Coley in the 19th century as a treatment for cancer, and is considered a precursor to modern cancer immunotherapy.…

Sounds of Science

1
All About Spheroids 26:54

לפני 5 weeks26:54

26:54

Spheroids are three dimensional cell models that can mimic some organs, tumors, and other biological systems for drug testing. Like organoids and organs-on-a-chip, spheroids are breaking in to drug development as a promising alternative to animal models. I am joined by Madhu Lal Nag, MBS PhD from the 3D in vitro model company InSphero, to discuss the development and future potential of these tiny cellular machines.…

Sounds of Science

1
Ep. 89: Rethinking Toxicology: The Future of NAMs in Agrochemicals 27:46

לפני 7 weeks27:46

27:46

The agrochemical field has long relied on animal models to evaluate the safety and efficacy of substances, but there’s a growing demand to adopt new alternative methods (NAMs) that can further the industry while reducing the need for animal testing. However, questions remain as to their long-term viability. Join Robert Landsiedel, Vice President of Experimental Toxicology and Ecology, and Susanne Kolle, Research Coordinator of Experimental Toxicology and Ecology at BASF, as they explain the benefits of NAMs, how they comply with the 3Rs principle, and the role collaboration is playing to push NAMs as a viable alternative to animals. Show Notes Alternative Methods AMAP Strategic Partnerships Animals in Research Modernizing Drug Development Agrochemical Testing Service for Approvals Chemical Testing Services Charles River Laboratories Announces Development of Nonclinical Virtual Control Groups with Sanofi to Reduce the Use of Animals Charles River Laboratories, in Collaboration with MatTek Corporation, Awarded Grant from the Foundation for Chemistry Research and Initiatives to Advance Research Alternatives…

Sounds of Science

1
Ep. 88: The Epidemiology of Cancer 31:29

לפני 9 weeks31:29

31:29

How can genetic, geographic, and social considerations effect outcomes for Black women with cancer? To answer this question, I am joined this week by Dr. Lauren E. McCullough, Associate Professor in the Department of Epidemiology at the Rollins School of Public Health, and Julia Schueler, Research Director Therapeutic Area Lead Oncology for Charles River. Dr. McCullough is also one of the lead researchers for the American Cancer Society’s VOICES of Black Women initiative, which will track the health of participants over several years to gain insight into health considerations for Black women. For more information on how to enroll, please visit voices.cancer.org .…

Sounds of Science

1
Ep. 87: Taking a Customized and Collaborative Approach to Therapeutic Development 28:49

לפני 11 weeks28:49

28:49

The N=1 Collaborative is changing the way we view drug development. Their specialty is creating customized therapies tailored to individual patients, paving the way for a unique approach that can leave long-lasting impacts on those with ultra-rare diseases. Join us as Executive Director Hugh Hempel discusses the origins of N=1, the collaborative effort it takes to advance customized therapies down the pipeline, and what the future holds for the field of individualized medicine. Show Notes n=1 Collaborative Rare Disease | Charles River Rare Disease Research for Drug Development Repurposing Drugs for Rare Disease S4 E07: Free For Life: The Story of N-Lorem Foundation…

Sounds of Science

1
Ep. 85: The Next Generation of Drug Development 26:01

לפני 13 weeks26:01

26:01

Artificial intelligence and machine learning are launching a new era in drug development. By integrating these technologies, researchers can get their life-saving therapies to patients faster thanks to more accurate data and efficient processes. Join us as Brian Roche, General Manager of Charles River’s integrated toxicology site in Kansas, as he discusses the advantages of using these advanced technologies, how their being leveraged across multiple platforms, and what role they play in shaping the future. Show Notes New Integrated Toxicology Site Kansas Site Unlocking the Promise of Integrated Toxicology: A Tour Through the Lab of the Future Meeting at the Intersection of Technology and Scientific Innovation…

Sounds of Science

1
Ep. 84: A Family's Fight Against Batten Disease 34:04

לפני 15 weeks34:04

34:04

David and Karen Kahn were overjoyed when they welcomed twins Amelia and Makenzie in 2010. However, it wasn't long before they realized their girls were different. Since getting their Batten disease diagnosis, they have worked tirelessly to find a treatment not only for their girls, but for kids around the world, with the help of researcher Dr. Michelle Hastings. Listen to their story now, and learn more about their mission at www.forebatten.org.…

Sounds of Science

1
Ep. 83: NAMs: The Future of Research? 24:31

לפני 18 weeks24:31

24:31

As researchers look for ways to reduce the need for animals in their studies, new alternative methods (NAMs) are an intriguing route to capture crucial safety data and help advance drug discovery and development – specifically, virtual control groups (VCGs). Join Steve Bulera, CVP and Chief Scientific Officer for Safety Assessment and Toxicology at Charles River, as he discusses how VCGs can be a viable alternative to research models, what it would take for the industry to widely accept NAMs, and how they can revolutionize research for the future. Show Notes Virtual Control Groups Sounds of Science E73: Virtual Control Groups Modernizing Drug Development with Virtual Control Groups Virtual Control Groups: A Data-Driven Novel Method Revolutionizing the Future of Safety Studies Charles River Laboratories Announces Development of Nonclinical Virtual Control Groups with Sanofi to Reduce the Use of Animals…

Sounds of Science

1
Ep. 82: Taking PrEP to the Next Level 29:11

לפני 20 weeks29:11

29:11

Dr. Jared Baeten, Senior Vice President of Clinical Development and Virology Therapeutic Area Head at Gilead Sciences, joins me to discuss the incredible advancements in pre-exposure prophylaxis (PrEP) treatments in honor of World AIDS Day. What if a twice yearly shot could replace a daily pill? Listen now to learn more!…

Sounds of Science

1
Ep. 81: Biomedical Engineering: The Future of Research? 32:16

לפני 22 weeks32:16

32:16

As researchers continue to look for new ways to test therapeutics in vitro , the field of biomedical engineering is offering new microphysiological systems that can reduce the need for animal models. Hear from Jeffrey Borenstein, Director of the Biomedical Engineering Centre at Draper, as he explains how it works, ways to expedite its access, and the benefits they will ultimately bring to patients. Show Notes The Coming of Age of Organ-on-a-Chip technology Sounds of Science E76: Multi-Organ Chip Systems Charles River Joins Consortium to Advance Organ-on-a-Chip Technology Bold New Approached: The Future of Organoid Intelligence Organoids Evolve from Academic Marvel to Industrial Tool…

Sounds of Science

1
Ep. 80: Diversity in Veterinary Medicine 44:55

לפני 24 weeks44:55

44:55

I am joined by Raphael (Ralph) Malbrue, Director & Attending Veterinarian, Center for Comparative Medicine, University of Virginia; and Christina (Winnie) Winnicker, Executive Director for Laboratory Animal Medicine for Charles River. Both bring a fresh perspective to the questions of how to improve diversity in veterinary medicine, how to inform new graduates of previously unconsidered career paths in lab animal medicine, and what kind of specialties are in demand in the industry now.…

Sounds of Science

1
Ep. 79: Painting a Picture of Hope to Treat PACS2 53:44

לפני 27 weeks53:44

53:44

Piotr Kosla, founder of the PACS2 Research Foundation, joins us to discuss his personal motivation to develop the first treatment for Development and Epileptic Encephalopathy 66 (PACS2 Syndrome), how cell painting assays are being used to repurpose a treatment for this condition, what the future holds for research in this area, and how you can help contribute to his mission. Show Notes PACS2 Research Foundation Eureka Blog | Drug Repurposing Through Cell Painting Could Treat Rare Disease ASO Screening Services Gene Therapy Services Art of Science: Cell Painting Free for Life: The Story of n-Lorem Foundation…

Sounds of Science

1
Ep. 78: Starting Over After Cancer 23:58

לפני 29 weeks23:58

23:58

Lisa Sharp, Project Coordinator for Charles River, joins us to discuss her COVID lockdown experience. Right at the beginning of the pandemic, just weeks apart, both she and her husband were diagnosed with cancer. Sadly, he didn't make it. While Lisa and their daughter faced the worst, she decided to make big changes to her life and career. Listen now to hear her story.…

Sounds of Science

1
Ep. 77: Ophirex: Biting Back 1:01:34

לפני 31 weeks1:01:34

1:01:34

Imagine you’re exploring the great outdoors when, out of nowhere, you feel the fangs of a snake – a poisonous snake – breaking through your skin. Medical care is nowhere in sight, so you’re left with the terrifying prospect of venom slowly infecting your body’s critical functions. This is the reality that roughly five million people face annually. Over 500,000 of which either die or are permanently maimed or suffer long-term cardiovascular/neurological impairments. However, Drs. Rebecca Carter and Matt Lewin are working to change that. Their work at Ophirex revolves around further developing Varespladib, a repurposed drug, as an accessible and affordable oral treatment to instantly combat venomous snakebites. By ingesting a small tablet or capsule, victims can buy time to seek out more advanced care, giving them a better chance to limit complications and prevent death. Join us as we explore the impacts snake venom has on the body, how Drs. Carter and Lewin discovered Varespladib, how collaborations and partnerships have benefited their development of this treatment, and what can be done to improve its accessibility, especially in remote areas of the world. Show Notes Ophirex Lifesaving Antidotes Antivenoms -_World Health Organization Interventions for the Preventing Reactions to Snake Venoms - National Institute of Health…

Sounds of Science

1
Ep. 76: Multi-Organ Chip Systems 31:31

לפני 33 weeks31:31

31:31

I am joined by Dr. Kacey Ronaldson-Bouchard from Columbia University, who is an expert on linking organs on a chip together to form models of human systems. Can these models replace animals? Can they save time and money in drug development and safety testing? Find out now when you listen to this podcast!…

Sounds of Science

1
Ep. 75: Porcine Kidneys for Human Transplant 22:05

לפני 37 weeks22:05

22:05

Mike Curtis, president and CEO of eGenesis, and transplant surgeon Dr. Leonardo Riella join me to discuss the ongoing research into pig kidney to human transplants. How can a porcine kidney be genetically modified to be safe for a human? Listen now to find out more.

Sounds of Science

1
Ep. 74: One Patient's Sickle Cell Story 13:41

לפני 41 weeks13:41

13:41

Felicia Samuel has worked for Charles River for years, but recently the work she contributes to has taken on a new meaning. Her daughter will be part of a clinical trial to receive one of the brand new sickle cell treatments, with the potential to drastically change her own and her family's lives. She joins me to discuss the details of this amazing but involved gene therapy process, and how working for one of the companies that contributed to this treatment's research makes her feel. You can read more about it here: https://www.criver.com/eureka/crispr-silences-sickle-cell…

Sounds of Science

1
Ep. 73: Virtual Control Groups 19:51

לפני 46 weeks19:51

19:51

What if we could replace mouse model control groups with a virtual equivalent? What would that mean for drug development in terms of cost, time, and animal model reduction? To answer, I am joined by Charles River associate director Laura Lotfi and Guillemette Duchateau-Nguyen from F. Hoffmann-La Roche Ltd, Pharmaceutical Sciences - Roche Innovation Center Basel. Listen now to learn how close we are to replacing some physical models with 1's and 0's.…

Sounds of Science

1
Ep. 72: Artificial Intelligence in Cell and Gene Therapy 27:04

לפני 50 weeks27:04

27:04

Alex Sargent, Director of Process Development at Charles River in our Cell and Gene Therapy department, joins me to discuss the work he and his partner put into developing an algorithm to make his job faster and easier. How can you train a computer to accurately sift through the mountains of data generated in drug development? Listen now to find out!…

Sounds of Science

1
Ep. 71: Cellular Agriculture - Lab Grown Meat of the Future 31:28

לפני 1 year31:28

31:28

There have been many articles recently about cellular agriculture, or lab-grown meat products. But what happens when a company takes a practical approach to this science fiction concept? Joining me are Charles River's Steven Miklasz from our Biologics Testing Solutions team; and Ramsey Foty, Scientific Director for Fork & Good, a cultivated meat company, to discuss how the sausage is made!…

Sounds of Science

1
Ep. 70: Benjamin Oakes and the Promise of CRISPR 28:49

לפני 1 year28:49

28:49

This month I am joined by Benjamin Oakes, scientist, entrepreneur, and co-founder of Scribe Therapeutics. He studied at UC Berkeley, working in the Doudna Lab and Savage Lab during the earliest days of CRISPR. We discuss his personal vision for the future of CRISPR, encouraging advances in the field, and the first ever drug approval for a CRISPR based therapy.…

Sounds of Science

1
Ep. 69: Past and Future of Endotoxin Testing 35:49

לפני 1 year35:49

35:49

Norm Wainwright and Foster Jordan have been immersed in the field of limulus amebocyte lysate (LAL) testing for decades, and have seen the progress and refinement of this crucial safety test. With the 20th anniversary of Charles River's Endosafe Cartridge and the recent introduction of recombinant alternatives, we look back at the past and future of endotoxin testing.…

Sounds of Science

1
Ep. 68: Looking Ahead in 2024 37:26

לפני 1 year37:26

37:26

I am joined by four experts in their field to discuss what will be hot in rare diseases, drug discovery, artificial intelligence, and animal models in 2024.

Sounds of Science

1
Ep. 67: A Rare Diagnosis 17:57

לפני 1 year17:57

17:57

Molly Dupre, a lab assistant at Charles River's Reno site, was recently diagnosed with Niemann-Pick Type B/ Acid Sphingomyelinase Deficiency. After years of waiting, doctor's visits, and tests, she could finally put a name to the condition that flared up after the birth of her son. But what came next? She joins me to tell her story.…

Sounds of Science

1
Ep. 66: When Drug Candidates Miss the Mark: Off-Target Liability 19:01

לפני 1 year19:01

19:01

Senior Principal Scientific Advisor Stan Spence joins me to discuss off-target liability: what happens when a drug misses its target? What are the risks to the patient if the off-target effects aren't caught early? Has there ever been an example of an off-target effect being beneficial to the patient? Find out here!…

Sounds of Science

1
BONUS: Life After Cancer With Rachel and Susan 17:32

לפני 2 years17:32

17:32

Rachel Kiserow and Susan Desmond have joined us year after year as part of Eureka's Breast Cancer Roundtable. This year, they wanted to share what happens after - after the treatments, after remission - life after cancer.

Sounds of Science

1
Ep. 65: The New England Compounding Center Tragedy 36:50

לפני 2 years36:50

36:50

For this episode, I am joined by Charles River's Doug Botkin and Pure Microbiology's Abby Roth to discuss the 2012 NECC meningitis outbreak. Doug and Abby bring their background in microbiology to explain how it happened, and how we can prevent such tragedies in the future.

Sounds of Science

1
Ep. 64: State of Oncology Report 32:37

לפני 2 years32:37

32:37

Charles River experts Justin Bryans and Elizabeth Anderson join me for a spirited discussion of where we are now in oncology research. Could we ever see a world without cancer?

Sounds of Science

1
Ep. 63: Gene Therapy Manufacturing: Two Perspectives 23:24

לפני 2 years23:24

23:24

Manufacturing gene therapies is a hot topic in the pharma field, on both the supplier and the client ends. Joining me to discuss this issue is Charles River Associate Director of Gene Therapy, Andrew Frazer, and Purespring Therapeutics' VP of Chemistry, Manufacturing and Controls, Amanda Weiss.

ברוכים הבאים אל Player FM!

Player FM סורק את האינטרנט עבור פודקאסטים באיכות גבוהה בשבילכם כדי שתהנו מהם כרגע. זה יישום הפודקאסט הטוב ביותר והוא עובד על אנדרואיד, iPhone ואינטרנט. הירשמו לסנכרון מנויים במכשירים שונים.